MedPath

A study to assess success after knee surgery

Phase 4
Conditions
Health Condition 1: M999- Biomechanical lesion, unspecified
Registration Number
CTRI/2023/04/051751
Lead Sponsor
Healthium Medtech Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male/ female participants between =18 years and = 45 years of age at the time of consent

2. Participants with traumatic ACL tears with or without associated meniscus injuries requiring primary ACL reconstruction surgery

3. Participants/ Legally Acceptable Representative who are willing to provide written Informed Consent and comply with study procedures

Exclusion Criteria

1. Participants with lateral/medial collateral ligament injury or posterior cruciate ligament injury

2. Participants with BMI =35 kg/m2

3. Participants who had undergone previous surgery in the same or contralateral knee

4. Participants with HbA1c ? 9% (Clinical laboratory reports up to 3 months will be considered valid otherwise participants will undergo blood investigation for HbA1C)

5. Participants who are smokers (smoking ?20 cigarettes/day)

6. Participants with sensitivity to PEEK material

7. Participants with a history of deep vein thrombosis (DVT)

8. Participants with arthritis of same or contralateral knee

9. Participants with any condition which makes the subject unsuitable for study participation which as per the investigator would jeopardize the outcome of the trial or participant who, in the judgment of the investigator, will be unlikely to comply with the requirements of this clinical investigation plan

10. Pregnant and lactating female at the time of screening

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To assess functional outcomes of Knee in each cohort of Peek button-open and Peek button-closed.Timepoint: Screening, month 3, month 6, month 12, month 18 and month 24
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath